Darling Ingredients (DAR) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 May, 2026Executive summary
Q1 2026 marked a significant turnaround with net sales rising 12.3% year-over-year to $1.6 billion and net income reaching $134.3 million, reversing a prior loss, driven by improved earnings power, operational excellence, and strong contributions from all segments and the DGD Joint Venture.
Diluted EPS improved to $0.83 from $(0.16) year-over-year.
Combined Adjusted EBITDA more than doubled to $406.8 million, up 107.8% from $195.8 million in Q1 2025.
Operating income surged to $226.8 million from $28.4 million year-over-year, reflecting higher prices, volumes, and improved margins.
Monetized $45 million in Production Tax Credit sales, enhancing liquidity.
Financial highlights
Gross margin improved to 26.1% from 22.6% year-over-year, with gross margin dollars at $404.9 million.
Net sales were $1.6 billion, up from $1.4 billion year-over-year.
Adjusted EBITDA by segment: Feed $168.7 million, Food $80.8 million, Fuel $179.9 million (including DGD share).
Cash and cash equivalents stood at $116 million; total debt at $4.13 billion; leverage ratio at 3.17x.
Capital expenditures for Q1 2026 were $94.8 million; $1.1 billion available on revolving credit facility.
Outlook and guidance
Q2 2026 core ingredients Adjusted EBITDA guidance is $260–275 million.
Management expects continued earnings growth, stronger cash flow, and further debt reduction throughout 2026.
DGD is expected to run near full capacity in Q2, with 320 million gallons guided.
FY 2026 capital expenditures estimated at $400 million, funded by operating cash flows.
Improving fat and fuel prices, along with regulatory support, are expected to benefit segment outlooks.
Latest events from Darling Ingredients
- All director nominees, auditor ratification, and key compensation plans were approved.DAR
AGM 202614 May 2026 - Accelerated growth, strong cash flow, and innovation in collagen set the stage for robust expansion.DAR
21st Annual Global Farm to Market Conference13 May 2026 - Global scale, strong cash flow, and innovation in renewables and collagen drive profitable growth.DAR
Investor Day 202611 May 2026 - Q4/FY2025 sales and margins rose, but net income fell sharply on restructuring charges.DAR
Q4 202512 Apr 2026 - Shareholders will vote on directors, auditor, executive pay, and a new incentive plan amid strong 2025 results.DAR
Proxy filing19 Mar 2026 - Virtual annual meeting to vote on directors, auditor, compensation, and incentive plan.DAR
Proxy filing19 Mar 2026 - Global leader in animal byproduct repurposing, poised for growth in food, feed, and renewables.DAR
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Net income and sales declined sharply in Q2, but EBITDA guidance and margin focus remain.DAR
Q2 20242 Feb 2026 - Bullish 2026 outlook with policy clarity, JV expansion, and strong growth in renewables and collagen.DAR
Jefferies Renewables & Clean Energy Conference22 Jan 2026